Christine Buttorff
Overview
Explore the profile of Christine Buttorff including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
44
Citations
358
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Buttorff C, Khodyakov D, Taylor E, Reid R, Sorbero M, Dworsky M
J Gen Intern Med
. 2024 Nov;
PMID: 39528723
No abstract available.
2.
Taylor E, Khodyakov D, Predmore Z, Buttorff C, Kim A
Health Aff Sch
. 2024 Oct;
2(10):qxae118.
PMID: 39416396
Specialty drugs are high-cost medications often used to treat complex chronic conditions. Even with insurance coverage, patients may face very high out-of-pocket costs, which in turn may restrict access. While...
3.
Buttorff C, Wang G, Wilks A, Tung G, Kress A, Schwam D, et al.
J Gen Intern Med
. 2023 Jun;
38(12):2726-2733.
PMID: 37340250
Background: Cannabis may be a substitute for opioids but previous studies have found conflicting results when using data from more recent years. Most studies have examined the relationship using state-level...
4.
Mulcahy A, Buttorff C, Finegold K, El-Kilani Z, Oliver J, Murphy S, et al.
Am J Manag Care
. 2022 Jul;
28(7):329-335.
PMID: 35852882
Objectives: Biologics account for an increasing share of US prescription drug spending. Biosimilars could lower biologic prices through competition, but barriers to increasing both supply and uptake remain. We projected...
5.
Wang G, Buttorff C, Wilks A, Schwam D, Tung G, Pacula R
Int J Drug Policy
. 2022 Apr;
104:103685.
PMID: 35429874
Background: Emergency department (ED) visits involving psychosis and schizophrenia have increased at a rate exceeding population growth in the United States over the past decade. Research shows a strong dose-response...
6.
Eibner C, Buttorff C, Cefalu M, Khodyakov D, Taylor E
Am J Health Promot
. 2022 Apr;
36(4):740-745.
PMID: 35420449
In 2015, the Centers for Medicare and Medicaid Services announced the Medicare Advantage (MA) Value-Based Insurance Design (VBID) model test, which allows MA insurers to use flexible benefit design strategies,...
7.
Buttorff C, Heins S, Al-Ibrahim H
Med Care Res Rev
. 2022 Mar;
79(6):861-870.
PMID: 35293244
Tracking injury rates is important for surveillance purposes but little data exist for injuries outside of emergency department visits. We assess the share and type of injuries reported in urgent...
8.
Buttorff C, Girosi F, Lai J, Taylor E, Lewis S, Ma S, et al.
Med Care
. 2022 Feb;
60(4):302-310.
PMID: 35213426
Objective: The objective of this study was to examine the price sensitivity for provider visits among Medicare Advantage beneficiaries. Data Sources: We used Medicare Advantage encounter data from 2014 to...
9.
Wang G, Buttorff C, Wilks A, Schwam D, Metz T, Tung G, et al.
Prev Med
. 2022 Feb;
156:106993.
PMID: 35150750
The primary objective of this study was to evaluate the association between presence of recreational cannabis dispensaries and prevalence of cannabis-involved pregnancy hospitalizations in Colorado. This was a retrospective cohort...
10.
Wang G, Buttorff C, Wilks A, Schwam D, Tung G, Banerji S, et al.
Am J Emerg Med
. 2022 Jan;
53:150-153.
PMID: 35051702
Introduction: Over the past 10 years, opioids and cannabis have garnered significant attention due to misuse and legalization trends. Different datasets and surveillance mechanisms can lead to different conclusions the...